It would be nice but it won't happen.
You will get to hear some words that sound like "striking results"
"DILUTIONS under not so favorable terms or OUT OF BUSINESS"
I agree with # 6 however, if Direct was showing tumor regression in phase 1 as per the slides Powers likes to show on what happened to mice, this stock would not have slid to 4 bucks. The only tid bits we have (and I don't know if it's the same guy) but the Nation Geo guy from Canada and the one case that started the MD Anderson/AF debacle. That is the only glimps into the COMPLETELY OPEN LABEL TRIAL.
Published results the only thing going to save this stock. Powers has stated she wants to start a phase 2 PRIOR to the Direct results. If she does this, Why is the big question mark I have. And the answer I'm guessing is going to be to keep "hope" alive and retail buying in on "hope". Positive results from Direct need to be published or this stock will go back to penny land. (it technically still is as NWBO did a reverse split of 16 to 1, which would put today's price at .25 prior to the split.
Really? I'm the dumb one? You are underwater on your shares (as well as I am on options) and it seems you are basing it on "hope" to make your money back or are being paid by NWBO to post on these boards.
I have listened to the webcasts. Maybe Linda didn't share those webcasts with those who were financing the last 2 deals which is why those terms were so poor... They should listen to webcast I guess...
So you believe Powers is sandbagging the results from Direct in order to get poor financing deals? If the results were stellar or "striking" as Powers would put it, there would people lining up to buy discounted share blocks. So why do you think that is? No one but retail investors has listened to the webcast? Is that what you think?
Well, to further your point, the Direct trial is open label, started 18 months ago and the last patient was 6 weeks ago. Do you really think the CEO (Powers) doesn't know how the unblinded open label Direct tria is doing that NWBO is funding?
The last two increasingly poor terms on the latest cash raise does not give me confidence that Direct is working like she had hoped.
It's been over a 18 months now since the trial started, Power's herself stated the response will been known quickly and since it's an open label phase 1, it's not blinded.
So who here thinks Linda knows no more than anyone else on these boards about Direct? I personally think she knows everything (and why wouldn't she? It's open label and she is the CEO funding the trial). Why also do you think we have had 2 cash raises in a few months and very poor terms.
Why do you think that is? I'm not bashing, but the stock price has been on a downward spiral and something tells me Direct isn't the end all we are hoping for.
well, lets hope he makes it. hard to tell currently if it's the transfusion, the "drugs" or both together that had the positive response to those who survived. The billion dollar question is if Duncan would have survived had he be given the drug within the first couple of days.
We will know in a couple of weeks after testing if CMRX's drug can work alone or not. I'm sure they are doing testing on primates as we speak. If it's proven to work alone (within an acceptable time frame from diagnosis, not 2 weeks later) things are bound to look very "up" for CMRX as their drug is the best choice due to ease of administering/storing and transporting it. On the flip side, it could be the antibodies that are saving these people, but I don't know if antibodies can be mass produced.
"there are trials with "striking results" all the time that catch the market unawares"
True, very true. Most all of them have a couple of things in common that NWBO seems to lack. 70+% tute ownership and a market cap north of 500 million when it happens.
NWBO has almost zero tute ownership, 8 people working there and a CEO who likes to use the word "striking" without anything to back it up. If the results from Direct are ever made public and they are "striking" I will gladly eat my words and gladly watch my account balance spike. But for now, all I have is "hope" and a diminishing value on my NWBO stock.
I think it's because what he wrote this time is actually spot on. I'm not bashing and I'm long on call options, but with all the people involved in the clinical trials, it would be difficult to keep "striking results" hush hush and funds would be falling over each other for discounted shares.. which isn't happening.
I've done a fair amount of reading on DC cells and the potential they may have. In theory NWBO may be on to something but they haven't shown ANYTHING that it works other than the words "striking results".
Why do you think each financing deal is worst than the last one? If NWBO was holding the "cure" like I would like to believe, word would be out and people would be begging to give them money for discounted shares.
The Direct trial has been going on for well over a year now, it's open label so everyone knows and can talk about the results they are seeing. Given the recent financing "deals" my guess is results aren't as "striking" as Powers wants everyone to believe, which is why -L increased it's size and Powers wants to start a phase 2 with Direct BEFORE results are even published for the phase one.
Powers may be able to pull a rabbit out of a hat and surprise everyone with her mixture of "special sauce", but I think there are too many people running the trials to keep "striking" results under wraps.
Just curious, but can you elaborate on "NWBO SCIENCE IS STRIKINGLY POSITIVE !!!!!!!"
NWBO hasn't really shared any "science that is strikingly positive" other than a very old study for -L and one brief case of Direct which is an open label study and has already treated everyone enrolled.
So until Direct results come out and come out very positive showing NWBO is the real deal, I'm afraid this will continue to slide back into penny stock land with no results, the continuing erosive share price and even worse financing deals.
I'm long options which are now out of the money.... and I'm tired of Power's using the word "striking" without anything to back it up.
"Do you know the clinical trial is blinded"
Do you really think Doctors are idiots and are unable to tell if a patient is responding to the drug or to placebo?
If Direct was working, don't you think the Doc's at Anderson would be blabbing their mouths? What about the GBM Doc's? The only blabbing we get is Powers stating "striking results" without presenting ANY striking results.
I'm long (on options) but this stock wouldn't drift down like this if in fact it was working. At least that is my opinion.
Wow, if this is true, you are going to make a lot of money or look back at what a bad idea this was.
I'm long, but have my doubts (won't give numbers on enrollment for L, little info on direct which is open label of all things, MFG is very "expensive" given the size of the current trials).
I'm hoping NWBO pulls a live rabbit out of the hat.. but that's all Power's is giving investors is hope instead of clinical results...
That is really one of the few points that AF makes that are completely valid. The CEO clearly stated twice about "efficacy analysis" would be completed at the last DMC review (last December).
Since the DMC stated it didn't happen, so why did Powers mis-lead investors about that review then subsequently increase the trial numbers?
Most everything else is moot point but Powers basically lied to her investors.